Modifications of peptide compositions to increase stability and delivery efficiency

Details for Australian Patent Application No. 2008206077 (hide)

Owner KAI Pharmaceuticals, Inc.

Inventors Maclean, Derek

Agent Griffith Hack

Pub. Number AU-A-2008206077

PCT Pub. Number WO2008/089491

Priority 60/945,285 20.06.07 US; 60/881,419 19.01.07 US

Filing date 22 January 2008

Wipo publication date 24 July 2008

International Classifications

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

Event Publications

27 August 2009 PCT application entered the National Phase

  PCT publication WO2008/089491 Priority application(s): WO2008/089491

17 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008206079-Method and device for selectively transmitting voice bursts and regenerated header bursts

2008206067-High strength cement, mortar and concrete including industrial by-products